Christian Hordo
Corporate Officer/Principal chez SANA BIOTECHNOLOGY, INC.
Fortune : 7 M $ au 31/05/2024
Profil
Christian Hordo is currently the Chief Business Officer & Executive Vice President at Sana Biotechnology, Inc. Prior to his current position, he served as the Vice President at Juno Therapeutics, Inc. from 2017 to 2018.
Mr. Hordo completed his undergraduate degree at McGill University, graduate degree at the University of Toronto, and holds an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC.
0,39% | 07/03/2024 | 867 455 ( 0,39% ) | 7 M $ | 31/05/2024 |
Postes actifs de Christian Hordo
| Sociétés | Poste | Début |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01/10/2018 |
Anciens postes connus de Christian Hordo
| Sociétés | Poste | Fin |
|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/10/2018 |
Formation de Christian Hordo
| Harvard Business School | Masters Business Admin |
| University of Toronto | Graduate Degree |
| McGill University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
